PSMLX | VSCPX | PSMLX / VSCPX | |
Total Expense Ratio | 0.74 | 0.03 | 2,467% |
Annual Report Gross Expense Ratio | 0.74 | 0.03 | 2,467% |
Fund Existence | 9 years | 15 years | - |
Gain YTD | 6.995 | 2.528 | 277% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 100000000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 2.13B | 154B | 1% |
Annual Yield % from dividends | 0.37 | 1.39 | 27% |
Returns for 1 year | 8.06 | 9.18 | 88% |
Returns for 3 years | 13.06 | 20.50 | 64% |
Returns for 5 years | 38.24 | 57.76 | 66% |
Returns for 10 years | N/A | 113.19 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
REPIX | 40.98 | 0.40 | +0.99% |
ProFunds Real Estate UltraSector Inv | |||
FBTAX | 30.03 | 0.26 | +0.87% |
Fidelity Advisor Biotechnology A | |||
ANDVX | 10.61 | N/A | N/A |
Virtus NFJ Dividend Value R6 | |||
CMNWX | 85.24 | -0.22 | -0.26% |
Principal Capital Appreciation A | |||
IMCGX | 11.18 | -0.06 | -0.53% |
Transamerica Mid Cap Growth I |